VanEck Genomics and Healthcare Innovators UCITS ETF
CURE.DE
#3164
ETF rank
ยฃ11.8 M
Marketcap
๐Ÿ‡ช๐Ÿ‡บ EU
Market
ยฃ15.95
Share price
-0.14%
Change (1 day)
-2.57%
Change (1 year)

Expense ratio and fees for VanEck Genomics and Healthcare Innovators UCITS ETF (CURE.DE)

Total Expense Ratio

Total Expense Ratio as of February 2026: 0.35%